Zhuangkai Liu - Concepedia

Author

Zhuangkai Liu

China Medical University

Also Known As

ZHUANGKAI LIU, Zhuang-kai Liu, Zhuangkai Liu

Publications

641

Citations

H-Index

Concepts

All Affiliations

China Medical University First Hospital of China Medical University Liaoning Cancer Hospital & Institute

About

Zhuangkai Liu is an author at China Medical University specializing in tumor biology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	535
2	Cell Biology	2	2	194
3	Public Health	1	1	35
4	Gastroenterology	1	1	207
5	Immunology	1	1	35

Zhuangkai Liu

Publications

593

Citations

H-Index

Page 1

	Year	Citations
Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance Yue Chen, Yongxi Song, Zhenning Wang, Journal of Gastrointestinal Surgery Tumor BiologyAltered ExpressionGastrointestinal OncologyMedicineGastroenterology	2010	207
microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer Yeun-po Chiang, Yongxi Song, Zhenning Wang, Experimental and Therapeutic Medicine Tumor BiologyOncologyMedicineColorectal CancerPathology	2011	99
Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers Yeun-po Chiang, Yongxi Song, Zhenning Wang, Journal of Gastrointestinal Surgery Tumor BiologyOncologyColorectal CancersMedicineAberrant Expression	2010	95
Inverse Association between miR-194 Expression and Tumor Invasion in Gastric Cancer Yongxi Song, Feng Zhao, Zhenning Wang, Annals of Surgical Oncology Tumor BiologyOncologyMedicinePathologyCancer Genomics	2011	60
Expression Levels of MicroRNA-192 and -215 in Gastric Carcinoma Yeun-po Chiang, Xin Zhou, Zhenning Wang, Pathology & Oncology Research PathologyGastric CarcinomaMicrorna DetectionMedicineCancer Research	2011	39
The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes Xiang Li, Ruishan Zhang, Zhuangkai Liu, Oncotarget Breast OncologyImmunologyGenetic EpidemiologyPathologyCancer Biology	2017	35
The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer Xinfeng Zhang, Dandan Wang, Zhuangkai Liu, Quantitative Imaging in Medicine and Surgery	2019	30
EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress Ruishan Zhang, Xiang Li, Zhuangkai Liu, Cancer Cell International	2020	28

Page 1